Gritstone bio (NASDAQ:GRTS) Downgraded by B. Riley to “Hold”
B. Riley lowered shares of Gritstone bio (NASDAQ:GRTS – Free Report) from a strong-buy rating to a hold rating in a report released on Tuesday, Zacks.com reports. B. Riley also issued estimates for Gritstone bio’s Q3 2024 earnings at ($0.14) EPS, Q4 2024 earnings at ($0.06) EPS, FY2024 earnings at ($0.62) EPS, FY2025 earnings at […]
5 Oct 01:12 · The Cerbat Gem